Regulatory Approvals

FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

By

Regulatory Approvals — FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class  STAT

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 16, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Iberdomide Plus Daratumumab and Dexamethasone for Multiple Myeloma

Regulatory Approvals

Dive into the Data Supporting the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma

Regulatory Approvals

Jim Baranski։ Precision Science and New FDA Approval for ROS1-Positive NSCLC

Financial News For All

Business Economy Finance

Commodities Price Update: Crude Oil $82.40, Brent $88.52, Copper $6.61, Coal $104.75 — Aug 16, 2026 8:00 AM EDT

Product Recalls

The Hampton Grocers, Inc . Recalls It’s 8 Ounce Packages of “Lacnola Lactation Granola” Because of Possible Health Risk

Product Recalls

TooyBing Wooden Bead Stacking Toys Recalled Due to Risk of Serious Injury or Death from Choking; Violate Small Parts Ban

Product Recalls

Taleco Gear Recalls Baby Jumpers, Baby Swings and 2-in-1 Baby Jumper & Swings Due to Risk of Serious Injury or Death from Fall and Strangulation Hazards